Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dynamic Pharmaceuticals Invesco ETF (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 489,436,500
  • Market Capitalization, $K 489,437
  • Shares Outstanding, K 7,350
  • 36-Month Beta 1.15
  • Price/Book 3.91
  • Price/Earnings ttm 15.53
  • Annual Dividend & Yield 0.70 (1.05%)
  • Most Recent Dividend 0.364 on 12/24/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.29 +13.07%
on 12/24/18
66.54 -0.95%
on 01/18/19
+6.38 (+10.72%)
since 12/21/18
3-Month
58.29 +13.07%
on 12/24/18
70.89 -7.02%
on 12/04/18
-2.55 (-3.72%)
since 10/22/18
52-Week
58.29 +13.07%
on 12/24/18
74.29 -11.28%
on 08/29/18
-3.53 (-5.08%)
since 01/22/18

Most Recent Stories

More News
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

AZN : 36.91 (+1.76%)
MRK : 75.19 (-0.84%)
PJP : 65.91 (-0.95%)
IHE : 145.90 (-1.07%)
PPH : 57.57 (-0.90%)
PFE : 42.00 (-0.64%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 85.84 (-0.19%)
BLUE : 125.09 (-3.75%)
IHE : 145.90 (-1.07%)
PJP : 65.91 (-0.95%)
IBB : 108.54 (-0.17%)
BBH : 125.60 (-1.63%)
IEIH : 25.22 (-1.25%)
BMY : 50.00 (+0.56%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 85.84 (-0.19%)
BLUE : 125.09 (-3.75%)
IHE : 145.90 (-1.07%)
PJP : 65.91 (-0.95%)
IBB : 108.54 (-0.17%)
BBH : 125.60 (-1.63%)
IEIH : 25.22 (-1.25%)
BMY : 50.00 (+0.56%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

MRK : 75.19 (-0.84%)
PJP : 65.91 (-0.95%)
IHE : 145.90 (-1.07%)
PPH : 57.57 (-0.90%)
NVS : 88.54 (+0.25%)
PFE : 42.00 (-0.64%)
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 39.65 (-1.47%)
MRK : 75.19 (-0.84%)
JNJ : 128.50 (-0.23%)
IHE : 145.90 (-1.07%)
PJP : 65.91 (-0.95%)
PPH : 57.57 (-0.90%)
PFE : 42.00 (-0.64%)
BMY : 50.00 (+0.56%)
FTXH : 20.18 (-1.42%)
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 39.65 (-1.47%)
MRK : 75.19 (-0.84%)
JNJ : 128.50 (-0.23%)
IHE : 145.90 (-1.07%)
PJP : 65.91 (-0.95%)
PPH : 57.57 (-0.90%)
PFE : 42.00 (-0.64%)
BMY : 50.00 (+0.56%)
FTXH : 20.18 (-1.42%)
ETF Strategies for the Midterm Elections

Investors should focus on some strategies as to which sector should they take positions or which should be avoided if bipartisan government forms.

TAN : 20.21 (-1.22%)
PPA : 52.37 (-1.69%)
GII : 47.41 (-0.82%)
IHE : 145.90 (-1.07%)
XAR : 83.42 (-2.59%)
IGF : 41.27 (-0.55%)
PPH : 57.57 (-0.90%)
KBE : 42.24 (-0.98%)
XPH : 39.65 (-1.47%)
ITA : 182.93 (-2.36%)
PJP : 65.91 (-0.95%)
ICLN : 8.84 (-1.23%)
KRE : 52.90 (-0.66%)
FTXH : 20.18 (-1.42%)
ETF Strategies for the Midterm Elections

Investors should focus on some strategies as to which sector should they take positions or which should be avoided if bipartisan government forms.

TAN : 20.21 (-1.22%)
PPA : 52.37 (-1.69%)
GII : 47.41 (-0.82%)
IHE : 145.90 (-1.07%)
XAR : 83.42 (-2.59%)
IGF : 41.27 (-0.55%)
PPH : 57.57 (-0.90%)
KBE : 42.24 (-0.98%)
XPH : 39.65 (-1.47%)
ITA : 182.93 (-2.36%)
PJP : 65.91 (-0.95%)
ICLN : 8.84 (-1.23%)
KRE : 52.90 (-0.66%)
FTXH : 20.18 (-1.42%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

AZN : 36.91 (+1.76%)
PJP : 65.91 (-0.95%)
IHE : 145.90 (-1.07%)
PPH : 57.57 (-0.90%)
PFE : 42.00 (-0.64%)
BMY : 50.00 (+0.56%)
Pharma & Biotech ETFs Soar on Trump's Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused these ETFs soaring.

XPH : 39.65 (-1.47%)
PBE : 52.11 (-2.10%)
SBIO : 31.57 (-2.38%)
PTH : 76.77 (-1.40%)
PJP : 65.91 (-0.95%)
IHE : 145.90 (-1.07%)
PPH : 57.57 (-0.90%)
GNRX : 21.55 (-0.92%)
PILL : 24.96 (-3.07%)
SPY : 263.78 (+0.35%)
FTXH : 20.18 (-1.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade PJP with:

Fund Summary

The Invesco Dynamic Pharmaceuticals ETF is based on the Dynamic Pharmaceutical Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies...

See More

Key Turning Points

2nd Resistance Point 66.38
1st Resistance Point 66.15
Last Price 65.91
1st Support Level 65.60
2nd Support Level 65.28

See More

52-Week High 74.29
Fibonacci 61.8% 68.18
Fibonacci 50% 66.29
Last Price 65.91
Fibonacci 38.2% 64.40
52-Week Low 58.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar